RAIN
Rain Oncology Inc. Common Stock
RAIN
RAIN
Delisted
RAIN was delisted on the 25th of January, 2024.
40 hedge funds and large institutions have $77.7M invested in Rain Oncology Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 5 increasing their positions, 15 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
-9
Holders Change %
-18.37%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
5
Reduced
15
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$1.85M |
| 2 |
LCM
Laurion Capital Management
New York
|
+$1.74M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$534K |
| 4 |
E
Ergoteles
New York
|
+$393K |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$380K |
Top Sellers
| 1 |
BlackRock
New York
|
-$3.68M |
| 2 |
State Street
Boston,
Massachusetts
|
-$933K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$680K |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$680K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$631K |
